ISIS Pharmaceuticals, Inc.

NASDAQ: ISIS
Tuesday's top analyst upgrades, downgrades and initiations include Apple, DuPont, Frontier Communications, Hewlett-Packard, HSBC, 3M and Red Hat.
Jon C. Ogg
It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the share price.
Jon C. Ogg
Credit Suisse expects that biotech stocks will see the most promotions in the coming rebalance of the Russell Indexes.
Lee Jackson
Monday's top analyst upgrades, downgrades and initiations include CenturyLink, IBM, Isis Pharmacutical, J.C. Penney and Wayfair.
Jon C. Ogg
Wednesday's top analyst upgrades, downgrades and initiations include Coupons.com, Dean Foods, Hilton, Isis Pharma, National Oilwell Varco and Stratasys.
Jon C. Ogg
In Thursday morning’s trading session, it seemed almost across the board that biotech stocks were the largest gainers.
Chris Lange
For many of the top biotech companies, orphan drugs have morphed into huge winners and have even generated other streams of revenue.
Lee Jackson
24/7 Wall St. is tracking several key movers this Monday that are unusual moves in nature. These are not due to mergers directly, so they are issues that investors and traders alike may track in the...
Jon C. Ogg
Source: ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise, is the...
Lee Jackson
Source: Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the...
Jon C. Ogg
These are the ten top Wall Street analyst calls with upgrades, downgrades, and initiations we have this Wednesday morning: Aflac (AFL) Cut to Hold from Buy at Citigroup. Campbell Soup (CPB) Raised to...
Douglas A. McIntyre
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and Genzyme Corp. (NASDAQ: GENZ) have entered into a major strategic alliance in which Genzyme will develop and commercialize mipomersen. Mipomersen is...
Douglas A. McIntyre
ISIS Pharmaceuticals Inc. (NASDAQ:ISIS) is trading up pre-market on new that it entered a broad collaboration with Ortho-McNeil, a Johnson & Johnson (NYSE:JNJ) unit, for discovery, development...
Douglas A. McIntyre
BIDU downgraded to hold at Citi. Wachovia lowers earnings estimates at INFY. AFT announces revenue for Q2 will be below Wall St. consensus. ISIS upgraded to strong buy at Needham. XFML says revenue...
Douglas A. McIntyre
Stock Tickers: CSCO, DNDN, CMGI, IBM, ISIS, RTP, FWLT, MVSN, TXN, ERTS So far this is turning out to be an interesting day, despite what looks to be very mixed and dull markets ahead of a Fed meeting...
Douglas A. McIntyre